Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc.

XLO
Xilio Therapeutics, Inc.US flagNASDAQ Global Select
8.70
USD
+0.13
- -
57.20MMarket Cap

Income Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
6
44
+ Sales & Services Revenue
- -
- -
- -
- -
- -
6
44
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
-6
-44
- Operating Expenses
19
55
75
89
79
66
86
+ Selling, General & Admin
5
11
24
30
27
25
30
+ Research & Development
14
44
51
59
52
41
56
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-19
-55
-75
-89
-79
-60
-42
- Non-Operating (Income) Loss
-2
1
1
-1
-3
-1
-7
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
-2
1
1
-1
-3
-1
-7
Pretax Income
-17
-55
-76
-88
-76
-58
-35
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-17
-55
-76
-88
-76
-58
-35
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-17
-55
-76
-88
-76
-58
-35
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-17
-55
-76
-88
-76
-58
-35
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-17
-55
-76
-88
-76
-58
-35
EBIT
-19
-55
-75
-89
-79
-60
-42
EBITDA
-19
-53
-74
-87
-77
-58
-40
EBITDA Margin (%)
- -
- -
- -
- -
- -
-914.27
-92.4
EBITA
-19
-55
-75
-89
-79
-60
-42
Gross Margin (%)
- -
- -
- -
- -
- -
100
100
Operating Margin (%)
- -
- -
- -
- -
- -
-940.18
-95.92
Profit Margin (%)
- -
- -
- -
- -
- -
-918.05
-80.05
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
1
1
2
2
2
2
Basic Weighted Avg Shares
2
2
- -
2
2
4
8
Basic EPS, GAAP
-9.09
-28.99
-189.29
-45.09
-38.9
-15.24
-4.19
Basic EPS from Cont Ops
-9.09
-28.99
-189.29
-45.09
-38.9
-15.24
-4.19
Diluted Weighted Avg Shares
2
2
- -
2
2
4
8
Diluted EPS, GAAP
-9.09
-28.99
-189.29
-45.09
-38.9
-15.24
-4.19
Diluted EPS from Cont Ops
-9.09
-28.99
-189.29
-45.09
-38.9
-15.24
-4.19

Balance Sheet (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
51
21
203
124
48
60
145
+ Cash, Cash Equivalents & STI
49
19
198
120
45
55
138
+ Cash & Cash Equivalents
49
19
198
120
45
55
138
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
5
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
5
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
2
1
4
4
3
5
2
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
12
16
16
15
13
11
10
+ Property, Plant & Equip, Net
10
14
14
13
11
9
8
+ Property, Plant & Equip
10
15
16
17
17
16
17
- Accumulated Depreciation
- -
1
3
4
6
7
9
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
2
2
2
2
2
2
2
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
2
2
2
2
2
2
2
Total Assets
63
36
218
139
61
71
155
+ Payables & Accruals
4
17
7
8
7
8
9
+ Accounts Payable
3
5
3
3
1
3
3
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
2
12
4
5
6
6
6
+ ST Debt
- -
3
1
8
4
1
1
+ ST Borrowings
- -
2
- -
7
3
- -
- -
+ ST Finance Leases
- -
1
1
1
1
1
1
+ Other ST Liabilities
1
2
5
5
5
18
46
+ Deferred Revenue
- -
- -
- -
- -
- -
14
40
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
2
5
5
5
4
6
Total Current Liabilities
5
22
13
21
16
27
56
+ LT Debt
19
18
20
12
8
7
6
+ LT Borrowings
10
7
10
3
- -
- -
- -
+ LT Finance Leases
9
11
10
9
8
7
6
+ Other LT Liabilities
68
79
- -
- -
- -
19
58
+ Accrued Liabilities
- -
- -
- -
- -
- -
19
21
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
68
79
- -
- -
- -
- -
37
Total Noncurrent Liabilities
87
97
20
12
8
26
63
Total Liabilities
92
120
33
34
24
53
119
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
2
346
355
362
401
454
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
2
346
355
362
401
454
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-30
-85
-161
-249
-326
-384
-419
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-30
-83
185
106
37
18
35
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
-30
-83
185
106
37
18
35
Total Liabilities & Equity
63
36
218
139
61
71
155
Shares Outstanding
2
2
2
2
2
3
5
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
9
11
11
10
9
8
7
Net Debt
-39
-9
-188
-111
-41
-55
-138
Net Debt to Equity
132.9
11.4
-101.62
-104.64
-112.39
-314.19
-389.9
Tangible Common Equity Ratio
-47.07
-229.33
85.04
75.91
60.45
24.76
22.8
Current Ratio
9.81
0.93
15.85
5.89
3.02
2.21
2.58
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-17
-55
-76
-88
-76
-58
-35
+ Depreciation & Amortization
- -
1
1
2
2
2
2
+ Non-Cash Items
-2
1
5
9
8
6
3
+ Stock-Based Compensation
- -
1
5
8
7
6
7
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
-2
- -
- -
- -
- -
- -
-4
+ Chg in Non-Cash Work Cap
1
17
-12
2
-2
32
25
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
-5
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
-3
2
-3
- -
1
-1
3
+ Inc (Dec) in Accts Payable
3
14
-8
2
-2
- -
-1
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
33
28
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-18
-36
-81
-76
-69
-18
-5
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-2
-1
-2
- -
- -
-1
+ Acq of Fixed Prod Assets
-1
-2
-1
-2
- -
- -
-1
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
116
- -
- -
7
41
+ Increase in Capital Stock
- -
- -
116
- -
- -
7
41
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
-2
-1
-2
- -
- -
-1
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
10
- -
- -
- -
-7
-3
- -
+ Cash From Debt
10
- -
1
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
-1
- -
-7
-3
- -
+ Other Financing Activities
50
10
144
- -
- -
26
47
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
60
10
261
- -
-7
29
88
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
41
-28
179
-78
-76
11
82
EBITDA
-19
-53
-74
-87
-77
-58
-40
EBITDA Margin (%)
- -
- -
- -
- -
- -
-914.27
-92.4
Free Cash Flow
-19
-38
-82
-78
-69
-18
-6
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-38
-82
-78
-76
-22
-6
Free Cash Flow per Basic Share
-9.74
-20.1
-204.4
-39.66
-35.19
-4.82
-0.66
Price/Free Cash Flow
- -
- -
-1.13
-1
-0.22
-2.79
-16.74
Cash Flow to Net Income
1.03
0.65
1.07
0.86
0.9
0.32
0.14
Capital Expenditures
-1
-2
-1
-2
- -
- -
-1